Abstract
A novel series of 1,2-benzisothiazol-3-one derivatives was synthesized and their biological activities were evaluated for inhibiting caspase-3 and -7 activities, in which some of them showed low nanomolar potency against caspase-3 in vitro and significant protection against apoptosis in a camptothecin-induced Jurkat T cells system. Among the tested compounds, compound 5i exhibited the most potent caspase-3 inhibitory activity (IC50=1.15 nM). The molecular docking predicted the interactions and binding modes of the synthesized inhibitor in the caspase-3 active site.
Keywords:
1,2-Benzisothiazol-3-one; Apoptosis; Caspase-3; Inhibitors.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Apoptosis / drug effects
-
Benzothiazoles / chemical synthesis
-
Benzothiazoles / chemistry*
-
Benzothiazoles / pharmacology
-
Binding Sites
-
Camptothecin / toxicity
-
Caspase 3 / chemistry*
-
Caspase 3 / metabolism
-
Caspase Inhibitors / chemical synthesis
-
Caspase Inhibitors / chemistry*
-
Caspase Inhibitors / pharmacology
-
Catalytic Domain
-
Humans
-
Jurkat Cells
-
Molecular Docking Simulation
-
Morpholines / chemical synthesis
-
Morpholines / chemistry*
-
Morpholines / pharmacology
-
Static Electricity
-
Thiazoles / chemical synthesis
-
Thiazoles / chemistry*
-
Thiazoles / pharmacology
Substances
-
Benzothiazoles
-
Caspase Inhibitors
-
Morpholines
-
N-(4-morpholinophenyl)-3-oxobenzo(d)isothiazole-2(3H)-carboxamide
-
Thiazoles
-
Caspase 3
-
1,2-benzisothiazoline-3-one
-
Camptothecin